Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Short-term Investments (2019 - 2025)

BridgeBio Pharma (BBIO) has disclosed Short-term Investments for 7 consecutive years, with $17.4 million as the latest value for Q4 2025.

  • Quarterly Short-term Investments changed N/A to $17.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.4 million through Dec 2025, changed N/A year-over-year, with the annual reading at $17.4 million for FY2025, N/A changed from the prior year.
  • Short-term Investments hit $17.4 million in Q4 2025 for BridgeBio Pharma, up from $3.0 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $459.2 million in Q2 2021 to a low of $177000.0 in Q4 2021.
  • Historically, Short-term Investments has averaged $132.8 million across 5 years, with a median of $47.5 million in 2023.
  • Biggest five-year swings in Short-term Investments: skyrocketed 21329.38% in 2022 and later plummeted 97.85% in 2025.
  • Year by year, Short-term Investments stood at $177000.0 in 2021, then surged by 21329.38% to $37.9 million in 2022, then soared by 55.42% to $58.9 million in 2023, then soared by 136.49% to $139.4 million in 2024, then crashed by 87.55% to $17.4 million in 2025.
  • Business Quant data shows Short-term Investments for BBIO at $17.4 million in Q4 2025, $3.0 million in Q3 2025, and $7.9 million in Q2 2025.